Fairvalue-Calculator Fairvalue-Calculator
EN DE

Carbios SAS, (ALCRB) Fair Value & Analysis

Basic Materials · FR · Market cap €139M

Price€6.09
Fair Value€8.55
Upside+40.4%
Quality92/100
Evidence: Low Range €5.37 – €10.70

Fair value as of: Jun 25, 2026

Analysis

Carbios SAS, (ALCRB) currently trades at €6.09, while our model-based Fair Value estimate is €8.55 — implying the stock looks roughly 40.4% undervalued today. We read business quality at 92/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Carbios SAS, engages in design and development of enzymatic processes in France. The company is also involved in enzymatic recycling and biodegradation activities. It exports its products. Carbios SAS was incorporated in 2011 and is headquartered in Clermont-Ferrand, France.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Carbios SAS, (ALCRB) undervalued?
As of Jun 25, 2026, our model estimates a fair value of €8.55 versus a price of €6.09 — about +40% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ALCRB?
Our 21-model fair value for Carbios SAS, is €8.55 (as of Jun 25, 2026), built from audited fundamentals. The current price is €6.09.
What is the quality score of ALCRB?
Carbios SAS, has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.